Eli Lilly CEO: The Weight-Loss Drug Revolution, AI in Pharma, and Innovation
In Good Company with Nicolai Tangen
00:00
Navigating Drug Development Challenges
This chapter explores the intricate process of drug discovery, emphasizing the hurdles pharmaceutical companies face in target identification and medication effectiveness. It discusses the role of artificial intelligence in enhancing efficiencies and the contrasting drug approval timelines between the US and Europe. Additionally, the chapter highlights China's rapid improvements in drug regulation and the evolving dynamics of its pharmaceutical market.
Transcript
Play full episode
